Polynovo Ltd at JPMorgan Healthcare Conference Transcript
Well, good morning, everyone. My name is Seth Schwartz. I lead JPMorgan's health care investment banking business in Australia. And I'd like to welcome Swami Raote to come up and present in relation to PolyNovo.
Thank you, Seth, and good morning all. It's indeed an honor and privilege to present at the 41st JPM, and thank you for the invite. PolyNovo, for many of you who might not be aware, is an Australian-listed stock exchange company. We've been around in existence for about 19 years. We have about 180 employees across the world, primarily in Australia and in the U.S.A., but also growing in other parts of the world.
Let me go through the disclaimer, and I would encourage all of you to read it. It's the standard notice. But there are three things which I would want you to take away from the PolyNovo presentation. One is, we have this amazing gem of a technology called NovoSorb. I call it a genius technology because throughout my 30 years of career, whenever I have thought about innovation, I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
